Oppenheimer Initiates Coverage on OSI Pharmaceuticals (OSIP)
OSIP Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Oppenheimer initiates coverage on OSI Pharmaceuticals (Nasdaq: OSIP) with a Perform rating.
To see more analyst ratings on OSIP Click Here.
OSI Pharmaceuticals, Inc. (OSI) is a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing unmet medical needs in oncology, diabetes and obesity.
To see more analyst ratings on OSIP Click Here.
OSI Pharmaceuticals, Inc. (OSI) is a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing unmet medical needs in oncology, diabetes and obesity.
You May Also Be Interested In
- UPDATE: Oppenheimer Starts Jazz Pharmaceuticals (JAZZ) at Outperform
- Nomura Securities Raises PT and Estimates on PetSmart (PETM) After Good Q1
- UBS Cuts Price Target and Estimates on Analog Devices (ADI); Good Q2, But Slowing Growth in N-T
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
